Publication | Open Access

Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design

Immunocytochemical TechniqueMedicineCellular Processing RatesBioanalysisImmunologyAntibody ScreeningAdc DesignImmunochemistryAntibody EngineeringImmunotherapyPharmacologyTrastuzumab-maytansinoid Antibody-drug ConjugateDrug Discovery